GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives $86.45 Consensus PT from Brokerages

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have received an average rating of “Moderate Buy” from the twelve brokerages that are currently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $86.4545.

A number of brokerages have recently issued reports on GEHC. BTIG Research reissued a “buy” rating and set a $87.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Wells Fargo & Company cut their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. Finally, Morgan Stanley raised their target price on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 30th.

GE HealthCare Technologies Trading Up 0.8%

NASDAQ:GEHC opened at $80.63 on Monday. The company’s 50 day moving average price is $74.84 and its 200-day moving average price is $74.07. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies has a 52 week low of $57.65 and a 52 week high of $94.80. The stock has a market cap of $36.73 billion, a price-to-earnings ratio of 16.66, a PEG ratio of 3.34 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities research analysts forecast that GE HealthCare Technologies will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in GE HealthCare Technologies by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock valued at $3,859,622,000 after buying an additional 703,903 shares in the last quarter. Dodge & Cox raised its stake in shares of GE HealthCare Technologies by 16.8% during the third quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock valued at $2,066,550,000 after acquiring an additional 3,949,361 shares in the last quarter. Capital Research Global Investors raised its stake in shares of GE HealthCare Technologies by 25.0% during the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after acquiring an additional 4,998,154 shares in the last quarter. State Street Corp boosted its holdings in shares of GE HealthCare Technologies by 1.9% in the second quarter. State Street Corp now owns 19,660,742 shares of the company’s stock valued at $1,456,271,000 after purchasing an additional 372,755 shares during the period. Finally, Geode Capital Management LLC grew its stake in GE HealthCare Technologies by 2.0% in the second quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock worth $881,060,000 after purchasing an additional 231,302 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.